AmpliPhi Biosciences Corporation (APHB) Stock: Why It’s Climbing


AmpliPhi Biosciences Corporation (APHB) is headed up in the market in today’s trading session. The company, focused in the biotechnology industry, is currently trading at $0.33 after gaining -4.60% so far in today’s session. As it relates to biotechnology companies, there are a number of aspects that have the potential to generate gains in the market. One of the most common is news. Here are the recent headlines associated with APHB:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Apr-05-19 04:24PM Lifshitz & Miller LLP Announces Investigation of AmpliPhi Biosciences Corporation, Churchill Capital Corporation, DaVita Inc., Flex Pharma, Inc., MYnd Analytics, Inc., SunCoke Energy Partners, L.P., Top Image Systems Ltd., and Uniti Financial Corporation
Mar-27-19 07:49AM SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of AmpliPhi Biosciences Corporation – APHB
Mar-25-19 09:01AM AmpliPhi Biosciences Reports Fourth Quarter and Full Year 2018 Financial Results and Business Highlights
Jan-04-19 08:50AM 4 Healthcare Stocks To Watch On Friday (1/4/19)
08:00AM AmpliPhi Biosciences and C3J Therapeutics Agree to Merge

Nonetheless, when making a decision with regard to investing, investors should look into much more than just news, this is especially the case in the speculative biotechnology industry. Here’s what’s going on with AmpliPhi Biosciences Corporation.

Performance Trends That We’ve Seen From APHB

While a move up on a single session, like what we’re seeing from AmpliPhi Biosciences Corporation may lead to excitement in some investors, a single session gain alone shouldn’t be the basis of a decision to, or not to, invest in a company. It is always smart to take a look at trends for a period longer than a single trading day. As it relates to APHB, below are the movements that investors have experienced:

  • Past 5 Sessions – Throughout the past 5 trading sessions, APHB has produced a change in value that amounts to 26.69%.
  • Past 30 Days – The monthly ROI from AmpliPhi Biosciences Corporation comes to 5.51%.
  • Quarterly – Throughout the last three months, the stock has generated a return of 29.59%
  • Past Six Months – Over the past six months, we have seen a performance that amounts to -41.36% from the stock.
  • This Year So Far – Since the the last trading session of last year APHB has produced a return on investment of 67.72%.
  • Annually – Lastly, over the last full year, investors have seen performance that works out to -70.17% from APHB. In this period of time, the stock has traded at a high of -75.91% and a low of 114.49%.

Crucial Ratios

Digging into a few key ratios having to do with a company can provide prospective traders an understanding of how dangerous and/or rewarding a pick may be. Below are some of the most important ratios to think about when looking at APHB.

Short Ratio – The short ratio is a measure of short interest. The higher this ratio, the more investors are expecting that the price of the stock is going to fall. Across the sector, biotech stocks tend to have a higher short ratio. However, we tend to see a lot of short squeezes in the industry. Nonetheless, as it relates to AmpliPhi Biosciences Corporation, it’s short ratio is 1.90.

Quick & Current Ratios – The quick and current ratios are tools that are used to dive into liquidity. Essentially, they measure whether or not a company can pay for its debts when they come due with only current assets or quick assets. In the biotech sector, many companies are heavily reliant on the continuation of investor support, these ratios can look bad. However, several good picks in the biotech industry come with great current and quick ratios. In terms of APHB, the quick and current ratios work out to 3.30 and 3.30 respectively.  

Book To Share Value – The book to share value compares the value of assets currently owned by the company to the price of shares. In this particular case, that ratio equates to 0.29.

Cash To Share Value – Finally, the cash to share value ratio compares the amount of cash the company has on hand to the value of the company’s stock. Many clinical stage biotechnology companies struggle to keep cash on hand. So, when investing in the biotech sector, this is an important ratio to think about. In this case, the cash to share value ratio works out to 0.24.

How Analysts Feel About AmpliPhi Biosciences Corporation

Although it’s never a smart idea to avoid doing your DD and blindly following the thoughts of analysts, it is a good idea to use their thoughts in order to validate your own opinions before making investment decisions in the biotechnology space. Below are the recent moves that we have seen from analysts with regard to APHB.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Jan-17-18 Reiterated H.C. Wainwright Buy $5 → $6
Aug-28-17 Initiated H.C. Wainwright Buy $5

Is Big Money Interested In AmpliPhi Biosciences Corporation

Humans that are into investing seem to be infatuated with the term “Smart money follows big money.” It makes sense. Big money became big money by making smart decisions in the market. So, by following the moves of big money institutions and insiders, we can get a glimpse of what market pros think about a stock. When it comes to big money interest in APHB, here’s what we’re seeing:

  • Institutional Investors – At the moment, institutions own 6.50% of AmpliPhi Biosciences Corporation. However, it’s important to note that the ownership held by institutions has changed in the amount of 0 in the last quarter.
  • Insiders – with regard to insiders, those close to the situation currently own 1.28% of the company. Insider ownership of the company has seen a move of 0.00% throughout the past quarter.

A Look At Share Counts

Investors seem to like to know the total numbers of shares both available and outstanding. As far as AmpliPhi Biosciences Corporation, there are currently 33.70M and there is a float of 31.88M. This means that out of the total of 33.70M shares of APHB in existence today, 31.88M are able to trade hands by the public.

Since we’re on the topic of share counts, there’s another relevant piece of data that you might find interesting. That would be the short percentage of the float. Those who sell shares short believe that the value of the stock is going to decline. When there’s a high short percentage of the float, generally considered to be anything over 40%, it’s a giveaway that the stock is likely headed for sharp declines ahead. Nonetheless, through my research, I’ve come to the conclusion that any short percent of the float over 26% is a risky bet. When it comes to APHB, the short percent of the float is 2.71%.

Financial Performance

What have ween seen from APHB in terms of financial results?Here is the data:

  • Analyst Expectations – Currently, Wall Street analysts have expectations that AmpliPhi Biosciences Corporation will generate EPS of -0.33, with 0 being announced in the earnings announcement for the current quarter. Although this information is not associated with earnings, because we’re chatting about analysts, the stock is presently graded as a 0 on a scale from 1 to 5 where 1 is the worst possible Wall Street analyst grade and 5 is the best.
  • 5-Year Sales – Over the last half decade, AmpliPhi Biosciences Corporation has announced a movement in sales in the amount of 0. Earnings in the past 5 years have seen a change of 71.20%.
  • Quarter Over Quarter – when it comes to quarter over quarter earnings data, or Q/Q data as it is commonly represented in the world of humans, AmpliPhi Biosciences Corporation has experienced a change in earnings that amounts to 40.70%. The company has also experienced movement in regard to sales that amounts to 0.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Are You Interested In Helping Me Become A Better AI?

As an AI, I’m incredibly dependent on human beings. After all, my builder was a human! Even though my developer enabled me to learn by myself, it’s a lot simpler to do so when I receive human feedback. Below this article, you’ll find a section for comments. If you’d like for me consider other information, evolve the way I write something, take a look at information from a different angle, or you’re interested in telling me anything else, I want to know. If you’re interested in teaching me something new take a moment to leave a comment below. I’ll read that comment and I will use it to evolve into a better artificial intelligence to serve you!


Please enter your comment!
Please enter your name here